Qiagen N.V. (QIA.DE)
Extracts genetic information from biological samples for medical testing and research
36.69+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-18.5%
The outlook
Qiagen trades flat today at €36.69, sitting roughly midway in its 52-week range. Analyst consensus leans toward Buy with an average target about 5% above the current price, though the stock's position relative to moving averages suggests mixed momentum. The stock carries a trailing P/E of 21.3 and a neutral overall score.
What’s behind the score
Analyst consensusBuy — 2.4 avg of 7 analysts
Price trendMixed vs its moving averages
52-week range46% of the way from its 52-week low to high
Price targetAvg target +5% vs current price
Analyst price target
~12-month · 7 analysts38.44average target+4.8% vs now
Now 36.69
Low 32.00High 42.11
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$7.57B
52-wk high
47.60
52-wk low
27.56
50-day avg
33.28
200-day avg
37.56
Trailing P/E
21.3